Egyptian Firm Minapharm to Develop Ebola Vaccine with $16.5M CEPI Funding
An Egyptian pharmaceutical firm, Minapharm, is developing a potential vaccine against the Bundibugyo strain of the Ebola virus raging in the Democratic Republic of Congo. Backed by up to $16.5 ... Read More